Natera, Inc. (NTRA)
Healthcare • Diagnostics & Research
StockNasdaqGSUnited StatesUS6323071042
322.94 USD
+0.98% today Updated 12 Nov 2026 21:22
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Natera, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 12 Nov 2026 21:22. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
25 Feb 2027
in 104 days · 16:00 · estimate -0.14
Last results
-0.42 vs -0.28 estimated
05 Nov 2026 · Miss -49.2%
Beat the estimate
7 of 12
5 missed · 0 in line
Average surprise
+14.2%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 25 Feb 2027 16:00 | -0.14 | — | — | Upcoming |
| 05 Nov 2026 16:00 | -0.28 | -0.42 | -49.2% | Miss |
| 06 Aug 2026 16:00 | -0.53 | -0.47 | +12.0% | Beat |
| 07 May 2026 16:00 | -0.55 | -0.60 | -8.5% | Miss |
| 26 Feb 2026 16:00 | -0.53 | 0.36 | +167.5% | Beat |
| 06 Nov 2025 16:00 | -0.35 | -0.64 | -80.7% | Miss |
| 07 Aug 2025 16:00 | -0.59 | -0.74 | -24.5% | Miss |
| 08 May 2025 16:00 | -0.66 | -0.50 | +24.2% | Beat |
| 27 Feb 2025 16:00 | -0.35 | -0.41 | -18.3% | Miss |
| 12 Nov 2024 16:00 | -0.59 | -0.26 | +56.2% | Beat |
| 08 Aug 2024 16:00 | -0.68 | -0.30 | +56.1% | Beat |
| 10 May 2024 06:00 | -0.75 | -0.56 | +25.8% | Beat |
| 28 Feb 2024 16:00 | -0.71 | -0.64 | +10.0% | Beat |
| 08 Nov 2023 16:00 | -0.97 | -0.95 | +1.9% | Beat |
| 03 Aug 2023 16:00 | -1.10 | -0.97 | +12.1% | Beat |
| 09 May 2023 16:00 | -1.16 | -1.23 | -6.0% | Miss |
| 28 Feb 2023 16:00 | -1.46 | -1.37 | +6.2% | Beat |
| 08 Nov 2022 16:00 | -1.44 | -1.25 | +13.2% | Beat |
| 04 Aug 2022 16:00 | -1.50 | -1.50 | -0.1% | In line |
| 05 May 2022 16:00 | -1.52 | -1.45 | +4.4% | Beat |
| 24 Feb 2022 16:00 | -1.31 | -1.49 | -13.3% | Miss |
| 04 Nov 2021 16:00 | -1.33 | -1.63 | -22.9% | Miss |
| 05 Aug 2021 16:00 | -1.20 | -1.32 | -9.6% | Miss |
| 06 May 2021 16:00 | -1.03 | -0.74 | +28.4% | Beat |
| 25 Feb 2021 16:00 | -0.66 | -0.91 | -37.9% | Miss |
| 05 Nov 2020 16:00 | -0.70 | -0.72 | -3.2% | Miss |
| 05 Aug 2020 16:00 | -0.60 | -0.68 | -12.5% | Miss |
| 06 May 2020 16:00 | -0.52 | -0.45 | +14.0% | Beat |
| 26 Feb 2020 16:00 | -0.54 | -0.45 | +17.2% | Beat |
| 06 Nov 2019 16:00 | -0.55 | -0.53 | +2.3% | Beat |
| 07 Aug 2019 16:00 | -0.56 | -0.48 | +15.0% | Beat |
| 09 May 2019 16:00 | -0.60 | -0.54 | +10.0% | Beat |
| 12 Mar 2019 16:00 | -0.51 | -0.51 | -0.5% | In line |
| 08 Nov 2018 16:00 | -0.48 | -0.49 | -2.6% | Miss |
| 08 Aug 2018 16:00 | -0.57 | -0.55 | +3.5% | Beat |
| 08 May 2018 16:00 | -0.62 | -0.61 | +2.4% | Beat |
| 13 Mar 2018 16:00 | -0.49 | -0.65 | -32.0% | Miss |
| 08 Nov 2017 16:00 | -0.48 | -0.51 | -6.8% | Miss |
| 08 Aug 2017 16:00 | -0.54 | -0.52 | +3.7% | Beat |
| 09 May 2017 16:00 | -0.67 | -0.70 | -4.2% | Miss |
| 07 Mar 2017 16:00 | -0.54 | -0.72 | -32.8% | Miss |
| 09 Nov 2016 16:00 | -0.56 | -0.50 | +11.1% | Beat |
| 04 Aug 2016 16:00 | -0.46 | -0.46 | -0.7% | In line |
| 10 May 2016 16:00 | -0.45 | -0.17 | +62.6% | Beat |
| 08 Mar 2016 16:00 | -0.67 | -0.47 | +29.9% | Beat |
| 12 Nov 2015 16:00 | -0.42 | -0.39 | +8.2% | Beat |
| 12 Aug 2015 16:00 | -0.44 | -0.34 | +23.3% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 2.3B | +35.9% | -208.2M | -9.0% | -1.52 | +0.7% | 76.1M |
| 2024 | 1.7B | +56.7% | -190.4M | -11.2% | -1.53 | +59.5% | 58.7M |
| 2023 | 1.1B | +32.0% | -434.8M | -40.2% | -3.78 | +32.1% | -286.2M |
| 2022 | 820.2M | — | -547.8M | -66.8% | -5.57 | — | -479.2M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 12 Nov 2026 | 310.99 | 326.92 | 304.65 | 322.94 | +0.98% | 1,499,546 | |
| 11 Nov 2026 | 320.61 | 325.35 | 314.45 | 319.82 | +2.51% | 1,746,200 | |
| 10 Nov 2026 | 318.65 | 323.73 | 307.08 | 311.98 | -2.62% | 1,751,100 | |
| 09 Nov 2026 | 311.08 | 324.77 | 308.02 | 320.39 | +3.13% | 2,784,300 | |
| 06 Nov 2026 | 319.99 | 327.53 | 304.00 | 310.67 | -14.59% | 5,775,800 | |
| 05 Nov 2026 | 377.46 | 379.50 | 354.01 | 363.76 | -6.97% | 3,225,400 | |
| 04 Nov 2026 | 393.42 | 397.00 | 369.51 | 391.03 | +0.62% | 2,800,400 | |
| 03 Nov 2026 | 385.77 | 398.03 | 382.10 | 388.63 | +2.56% | 3,880,900 | |
| 02 Nov 2026 | 418.41 | 418.41 | 376.38 | 378.92 | -8.54% | 2,626,800 | |
| 30 Oct 2026 | 425.55 | 431.26 | 408.33 | 414.30 | -4.98% | 2,431,900 | |
| 1,250 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- The Fund Exited Natera (NTRA) on Valuation Concerns Despite Strong Fundamentals (opens in a new tab) Insider Monkey · 11 Nov 2026 16:04
- Carrier Screening - Global Strategic Business Report 2026: Secure Your Share of a $7.6 Billion Market by 2032 | Features Competitive Intelligence on Illumina, Natera, BGI Genomics, and Myriad Genetics (opens in a new tab) 11 Nov 2026 14:25
- Strong Q2 Results and Raised Revenue Guidance Drive Natera’s (NTRA)Outperformance (opens in a new tab) Insider Monkey · 11 Nov 2026 14:21
- Natera, Inc. (NTRA) Presents at 2026 UBS Global Healthcare Conference Transcript (opens in a new tab) SeekingAlpha · 11 Nov 2026 13:39
- Natera and Incyte partner on Phase II colorectal cancer trial (opens in a new tab) Clinical Trials Arena · 11 Nov 2026 11:19
- Natera, Inc. (NTRA) Presents at 8th Annual Wolfe Research Healthcare Conference Transcript (opens in a new tab) SeekingAlpha · 11 Nov 2026 08:08
- Natera Announces Clinical Collaboration with Incyte on Interventional Phase II Study in Colorectal Cancer (opens in a new tab) 10 Nov 2026 12:00
- Natera Enters Into Clinical Collaboration Agreement With Incyte For New Phase II Study In Colorectal Cancer (opens in a new tab) Benzinga · 10 Nov 2026 08:10
- Natera Q3 Earnings Call Highlights $6B Target & Raised 2026 Outlook (opens in a new tab) Zacks · 09 Nov 2026 17:29
- NTRA Q3 2026 deep dive: management transition and pharma business investments offset margin gains (opens in a new tab) StockStory · 09 Nov 2026 11:01
- Baird Maintains Outperform on Natera, Lowers Price Target to $403 (opens in a new tab) Benzinga · 09 Nov 2026 07:43
- Natera (NTRA) Hands CEO Role To Longtime Insider As New Cancer Data Lands (opens in a new tab) Simply Wall St. · 07 Nov 2026 11:11
- Natera, Inc. (NTRA) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 07 Nov 2026 04:54
- Natera, Inc. 2026 Q3 - Results - Earnings Call Presentation (opens in a new tab) SeekingAlpha · 07 Nov 2026 01:01
- It Was Already A Gory Day For Blood-Testing Stocks — Then, Natera And Guardant Reported (opens in a new tab) Investor's Business Daily · 06 Nov 2026 21:10
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 319.82 USD
- Market cap
- 46.5B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow NTRA and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.